Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
310.15
-3.59 (-1.14%)
May 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Oncology | 666.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Growth | 11.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Metabolic | 501.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Metabolic Growth | 27.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Sources of | 418.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Sources of Growth | -1.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiology | 233.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiology Growth | 14.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System | 192.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Growth | 16.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AVAI | 143.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AVAI Growth | -17.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Net New Business Awards | 2.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Net New Business Awards Growth | -18.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Backlog | 2.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Backlog Growth | -2.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|